These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8540736)

  • 21. Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents.
    Frean J; Klugman KP; Arntzen L; Bukofzer S
    J Antimicrob Chemother; 2003 Aug; 52(2):294-6. PubMed ID: 12865386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enrichment of Yersinia pestis from blood cultures enables rapid antimicrobial susceptibility determination by flow cytometry.
    Steinberger-Levy I; Zahavy E; Cohen S; Flashner Y; Mamroud E; Aftalion M; Gur D; Ber R
    Adv Exp Med Biol; 2007; 603():339-50. PubMed ID: 17966430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibiotic effect on plague microbe antigens].
    Aparin GP
    Antibiotiki; 1973 Aug; 18(8):728-31. PubMed ID: 4776408
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
    J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.
    Steward J; Lever MS; Russell P; Beedham RJ; Stagg AJ; Taylor RR; Brooks TJ
    Int J Antimicrob Agents; 2004 Dec; 24(6):609-12. PubMed ID: 15555886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro and in vivo effects of trimethoprim-sulfamethoxazole on Yersinia pestis].
    Nguyên-Van-Ai ; Nguyên-Duc-Hanh ; Pham-Van-Diên ; Nguyên-Van-Lê
    Bull Soc Pathol Exot Filiales; 1972; 65(6):759-64. PubMed ID: 4679265
    [No Abstract]   [Full Text] [Related]  

  • 27. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.
    Galimand M; Guiyoule A; Gerbaud G; Rasoamanana B; Chanteau S; Carniel E; Courvalin P
    N Engl J Med; 1997 Sep; 337(10):677-80. PubMed ID: 9278464
    [No Abstract]   [Full Text] [Related]  

  • 28. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis].
    Zurabyan VA; Pavlovich NV; Makarovskaya LN; Ryzhkova VV; Bugaeva OK
    Antibiot Khimioter; 1997; 42(11):22-5. PubMed ID: 9463297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmid-mediated doxycycline resistance in a Yersinia pestis strain isolated from a rat.
    Cabanel N; Bouchier C; Rajerison M; Carniel E
    Int J Antimicrob Agents; 2018 Feb; 51(2):249-254. PubMed ID: 29030266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis.
    Lonsway DR; Urich SK; Heine HS; McAllister SK; Banerjee SN; Schriefer ME; Patel JB
    J Clin Microbiol; 2011 May; 49(5):1956-60. PubMed ID: 21411569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibiotic sensitivity of strains of the plague microbe isolated from foci in the Caucasus and Transcaucasia].
    Tarasova VE; Eremitskaia GN; Proskurina VA
    Antibiotiki; 1981 May; 26(5):365-7. PubMed ID: 7259143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic Therapy of Plague: A Review.
    Sebbane F; Lemaître N
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34065940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice.
    Russell P; Eley SM; Bell DL; Manchee RJ; Titball RW
    J Antimicrob Chemother; 1996 Apr; 37(4):769-74. PubMed ID: 8722542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicopy suppressor screening approach as a means to identify antibiotic resistance determinant candidates in Yersinia pestis.
    Stirrett KL; Ferreras JA; Rossi SM; Moy RL; Fonseca FV; Quadri LE
    BMC Microbiol; 2008 Jul; 8():122. PubMed ID: 18644132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of oily chloramphenicol depot injection to treat plague in a murine model.
    Rahalison L; Guiyoule A; Bonacorsi SP; Slacanin I; Chanteau S; Carniel E
    J Antimicrob Chemother; 2000 Apr; 45(4):541-5. PubMed ID: 10747836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))].
    Ryzhko IV; Trishina AV; Verkina LM
    Antibiot Khimioter; 2010; 55(11-12):22-4. PubMed ID: 21574421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.
    McLaughlin HP; Sue D
    BMC Microbiol; 2018 Dec; 18(1):218. PubMed ID: 30563467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yersinia pestis and approaches to targeting its outer protein H protein-tyrosine phosphatase (YopH).
    Bahta M; Burke TR
    Curr Med Chem; 2012; 19(33):5726-34. PubMed ID: 22934808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.